Get Started

JAN

JanOne (JAN)

JanOne Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:JAN

1 2 3 4 5 6 Next >>

Date	Time	Source	Headline	Symbol	Company
05/16/2024	4:00PM	PR Newswire (US)	JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain Fintech	NASDAQ:JAN	JanOne Inc
05/13/2024	7:30AM	PR Newswire (US)	JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider	NASDAQ:JAN	JanOne Inc
05/10/2024	4:10PM	PR Newswire (US)	JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider	NASDAQ:JAN	JanOne Inc
05/06/2024	4:59PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JAN	JanOne Inc
05/06/2024	4:57PM	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:JAN	JanOne Inc
03/15/2024	9:00AM	PR Newswire (US)	JanOne Regains Compliance with Nasdaq's Listing Requirements	NASDAQ:JAN	JanOne Inc
02/28/2024	4:22PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JAN	JanOne Inc
02/09/2024	12:36PM	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:JAN	JanOne Inc
02/08/2024	4:07PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JAN	JanOne Inc
01/12/2024	4:28PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JAN	JanOne Inc
10/11/2023	4:33PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JAN	JanOne Inc
09/22/2023	5:00PM	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:JAN	JanOne Inc
09/21/2023	11:30AM	PR Newswire (US)	JanOne to Present at the Dawson James 8th Annual Investment Conference	NASDAQ:JAN	JanOne Inc
09/21/2023	9:35AM	GlobeNewswire Inc.	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference	NASDAQ:JAN	JanOne Inc
09/15/2023	4:33PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JAN	JanOne Inc
08/31/2023	1:30PM	PR Newswire (US)	JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference	NASDAQ:JAN	JanOne Inc
08/29/2023	1:30PM	PR Newswire (US)	JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain	NASDAQ:JAN	JanOne Inc
08/28/2023	5:20PM	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:JAN	JanOne Inc
08/25/2023	2:30PM	PR Newswire (US)	JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting	NASDAQ:JAN	JanOne Inc
08/24/2023	4:30PM	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:JAN	JanOne Inc
08/23/2023	4:33PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JAN	JanOne Inc
08/22/2023	5:30PM	PR Newswire (US)	JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules	NASDAQ:JAN	JanOne Inc
08/22/2023	12:54PM	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:JAN	JanOne Inc
08/18/2023	7:00PM	PR Newswire (US)	JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules	NASDAQ:JAN	JanOne Inc
08/18/2023	12:42PM	PR Newswire (US)	JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting	NASDAQ:JAN	JanOne Inc
08/16/2023	3:55PM	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:JAN	JanOne Inc
08/15/2023	4:39PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:JAN	JanOne Inc
07/07/2023	4:19PM	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:JAN	JanOne Inc
06/30/2023	4:24PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JAN	JanOne Inc
06/28/2023	8:30AM	PR Newswire (US)	JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain	NASDAQ:JAN	JanOne Inc